BR9809498A - Compound, process for its production, pharmaceutical composition, process for its production, and processes for treating HIV infection, for treating AIDS, for inhibiting a hiv protease, and for producing an ethanolate solvate. - Google Patents
Compound, process for its production, pharmaceutical composition, process for its production, and processes for treating HIV infection, for treating AIDS, for inhibiting a hiv protease, and for producing an ethanolate solvate.Info
- Publication number
- BR9809498A BR9809498A BR9809498-0A BR9809498A BR9809498A BR 9809498 A BR9809498 A BR 9809498A BR 9809498 A BR9809498 A BR 9809498A BR 9809498 A BR9809498 A BR 9809498A
- Authority
- BR
- Brazil
- Prior art keywords
- production
- treating
- compound
- processes
- hiv protease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"COMPOSTO CRISTALINO, PROCESSO PARA SUA PRODUçãO, COMPOSIçãO FARMACêUTICA, PROCESSO PARA SUA PRODUçãO, E, PROCESSOS PARA TRATAMENTO DE INFECçãO PELO HIV, PARA TRATAMENTO DA AIDS E PARA INIBIçãO DE UMA HIV PROTEASE". Esta invenção diz respeito a um sal de sulfato de um inibidor da HIV protease, Composto (A) que é útil no tratamento da infecção de AIDS, ARC ou HIV em adultos e crianças. Mais especificamente, a invenção fornece um sal de sulfato do inibidor da HIV protease, Composto (A), tendo solubilidade substancialmente melhorada em solução diluída de HC1 (ácido gástrico), que resulta em absorção oral e biodisponibilidade muito maiores em modelos de animais. Processos para produzir o sal de sulfato dos compostos específicos inibidores de HIV protease, também são apresentados."CRYSTALLINE COMPOUND, PROCESS FOR ITS PRODUCTION, PHARMACEUTICAL COMPOSITION, PROCESS FOR ITS PRODUCTION, AND, PROCESSES FOR TREATING HIV INFECTION, FOR TREATING AIDS AND FOR INHIBITING HIV PROTEASE". This invention relates to a sulfate salt of an HIV protease inhibitor, Compound (A) which is useful in the treatment of AIDS, ARC or HIV infection in adults and children. More specifically, the invention provides a sulfate salt of the HIV protease inhibitor, Compound (A), having substantially improved solubility in diluted HCl (gastric acid) solution, which results in much greater oral absorption and bioavailability in animal models. Processes for producing the sulfate salt of specific HIV protease inhibitor compounds are also presented.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4795097P | 1997-05-29 | 1997-05-29 | |
| GBGB9714320.0A GB9714320D0 (en) | 1997-07-07 | 1997-07-07 | Hiv protease inhibitor |
| PCT/US1998/010633 WO1998054178A1 (en) | 1997-05-29 | 1998-05-26 | Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9809498A true BR9809498A (en) | 2000-06-20 |
Family
ID=26311845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9809498-0A BR9809498A (en) | 1997-05-29 | 1998-05-26 | Compound, process for its production, pharmaceutical composition, process for its production, and processes for treating HIV infection, for treating AIDS, for inhibiting a hiv protease, and for producing an ethanolate solvate. |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0986554A1 (en) |
| JP (1) | JP3267632B2 (en) |
| KR (1) | KR20010013042A (en) |
| CN (1) | CN1257497A (en) |
| AU (1) | AU730245B2 (en) |
| BG (1) | BG103923A (en) |
| BR (1) | BR9809498A (en) |
| CA (1) | CA2291086A1 (en) |
| EA (1) | EA199901095A1 (en) |
| EE (1) | EE9900543A (en) |
| HR (1) | HRP980283A2 (en) |
| HU (1) | HUP0004621A3 (en) |
| ID (1) | ID23858A (en) |
| IL (1) | IL132779A0 (en) |
| IS (1) | IS5240A (en) |
| NO (1) | NO995822L (en) |
| PE (1) | PE75099A1 (en) |
| PL (1) | PL336847A1 (en) |
| SK (1) | SK163299A3 (en) |
| TR (1) | TR199902816T2 (en) |
| TW (1) | TW438799B (en) |
| WO (1) | WO1998054178A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60036961T2 (en) * | 1999-11-24 | 2008-08-28 | Merck & Co., Inc. | GAMMA-HYDROXY-2- (FLUORALKYLAMINOCARBONYL) -1-PIPERAZINE PENTANAMIDE AS AN HIV PROTEASE INHIBITOR |
| US20020082421A1 (en) * | 2000-09-14 | 2002-06-27 | Abdel-Magid Ahmed F. | Novel solid salt forms of N-[2-[4-[2-(1- methylethoxy)phenyl]-1-piperazinyl]-2-oxo-1piperidineacetamide |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU692509B2 (en) * | 1993-12-15 | 1998-06-11 | Merck & Co., Inc. | HIV protease inhibitors |
-
1998
- 1998-05-20 TW TW087107834A patent/TW438799B/en active
- 1998-05-26 WO PCT/US1998/010633 patent/WO1998054178A1/en not_active Application Discontinuation
- 1998-05-26 SK SK1632-99A patent/SK163299A3/en unknown
- 1998-05-26 BR BR9809498-0A patent/BR9809498A/en not_active Application Discontinuation
- 1998-05-26 IL IL13277998A patent/IL132779A0/en unknown
- 1998-05-26 HU HU0004621A patent/HUP0004621A3/en unknown
- 1998-05-26 ID IDW991462A patent/ID23858A/en unknown
- 1998-05-26 JP JP50079999A patent/JP3267632B2/en not_active Expired - Fee Related
- 1998-05-26 PL PL98336847A patent/PL336847A1/en unknown
- 1998-05-26 EP EP98923741A patent/EP0986554A1/en not_active Withdrawn
- 1998-05-26 CA CA002291086A patent/CA2291086A1/en not_active Abandoned
- 1998-05-26 AU AU75959/98A patent/AU730245B2/en not_active Ceased
- 1998-05-26 EA EA199901095A patent/EA199901095A1/en unknown
- 1998-05-26 EE EEP199900543A patent/EE9900543A/en unknown
- 1998-05-26 KR KR1019997011018A patent/KR20010013042A/en not_active Application Discontinuation
- 1998-05-26 TR TR1999/02816T patent/TR199902816T2/en unknown
- 1998-05-26 CN CN98805372A patent/CN1257497A/en active Pending
- 1998-05-28 HR HR9714320.0A patent/HRP980283A2/en not_active Application Discontinuation
- 1998-05-28 PE PE1998000432A patent/PE75099A1/en not_active Application Discontinuation
-
1999
- 1999-11-09 IS IS5240A patent/IS5240A/en unknown
- 1999-11-24 BG BG103923A patent/BG103923A/en unknown
- 1999-11-26 NO NO995822A patent/NO995822L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO995822D0 (en) | 1999-11-26 |
| PE75099A1 (en) | 1999-08-11 |
| EE9900543A (en) | 2000-06-15 |
| HUP0004621A2 (en) | 2002-03-28 |
| AU730245B2 (en) | 2001-03-01 |
| JP3267632B2 (en) | 2002-03-18 |
| CN1257497A (en) | 2000-06-21 |
| EA199901095A1 (en) | 2000-08-28 |
| SK163299A3 (en) | 2000-07-11 |
| CA2291086A1 (en) | 1998-12-03 |
| HRP980283A2 (en) | 1999-08-31 |
| AU7595998A (en) | 1998-12-30 |
| TR199902816T2 (en) | 2000-02-21 |
| KR20010013042A (en) | 2001-02-26 |
| HUP0004621A3 (en) | 2002-04-29 |
| NO995822L (en) | 2000-01-28 |
| BG103923A (en) | 2000-06-30 |
| EP0986554A1 (en) | 2000-03-22 |
| WO1998054178A1 (en) | 1998-12-03 |
| IL132779A0 (en) | 2001-03-19 |
| ID23858A (en) | 2000-05-25 |
| IS5240A (en) | 1999-11-09 |
| JP2000513747A (en) | 2000-10-17 |
| PL336847A1 (en) | 2000-07-17 |
| TW438799B (en) | 2001-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9600834D0 (en) | Quinazoline derivatives | |
| BR9006264A (en) | AMINO ACID DERIVATIVES AND PROCESS FOR THEIR PRODUCTION, DRUGS, USES OF AN AMINO ACID DERIVATIVE AND PROCESS FOR TREATING OR PREVENTING VIROTIC INFECTIONS | |
| DK0661269T3 (en) | Substituted heterocyclic carboxylic acid amides, their preparation and use as drugs. | |
| FI895492A0 (en) | Process for the preparation of an aqueous pharmaceutical composition containing N- (3,4-dimethoxycinnamoyl) anthranilic acid | |
| DK0650961T3 (en) | Substituted heterocyclic carboxylic acid amides, their preparation and their use as drugs. | |
| DE60037836D1 (en) | ThiazoloÄ4,5-diphyrimidine compounds for the treatment of rheumatoid arthritis | |
| ATE212837T1 (en) | PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ACUTE RHINITIDES, CONTAINING SYMPTHOMIMETICUM AND PANTOTHENOL AND/OR PANTOTHENIC ACID | |
| MXPA05013607A (en) | Improved pharmaceutical drug candidates and methods for preparation thereof. | |
| BR9915729A (en) | Egamega amides of n-arylsulfonyl-amino acid | |
| BR9809498A (en) | Compound, process for its production, pharmaceutical composition, process for its production, and processes for treating HIV infection, for treating AIDS, for inhibiting a hiv protease, and for producing an ethanolate solvate. | |
| BR9407862A (en) | Flavin compound flavin derived from flavin or a mixture comprising two or more of these pharmaceutical composition and process for treatment by prophylaxis or therapy of disease caused by viral infection | |
| PT92952A (en) | PROCESS FOR THE PREPARATION OF 3-PHENYL-5,6-DIHYDROBENZ (C) ACRIDINE-7-CARBOXYLIC ACIDS, RELATED COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| ATE69049T1 (en) | QUINAZOLINE DERIVATIVE, PROCESS FOR PRODUCTION THEREOF AND AGENT FOR TREATMENT OF CEREBRAE DISFUNCTION AS ACTIVE INGREDIENT. | |
| DE69209166D1 (en) | Diclofenac choline salt, method of manufacture and pharmaceutical compositions containing it | |
| PT94880A (en) | 2,3-DIHYDRO-1- (PYRIDINYL-AMINO) -INDS AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| DK492989D0 (en) | AMINOPYRROLIDINON, PHARMACEUTICAL PREPARATION CONTAINING SUCH A CONNECTION AND PROCEDURE FOR PRODUCING THEREOF | |
| ES2196174T3 (en) | `DERIVATIVES OF SESQUITERPENO OF ANTIVIRAL ACTIVITY. | |
| EP0383481A3 (en) | Anesthetic oral compositions | |
| TW200517367A (en) | Improved pharmaceutical drug candidates and methods for preparation thereof | |
| BR0009277A (en) | Preparation process of 3s-3-amino-3-aryl propionic acid and derivatives thereof | |
| ATE135217T1 (en) | PHARMACEUTICAL COMPOSITIONS FOR AIDS TREATMENT | |
| BR0113814A (en) | Phenylcyclohexanecarboxylic acid amides and their application | |
| SE8503109D0 (en) | CYCLIC PRODRUGS OF ANTIINFLAMMATORY OXICAMS | |
| ES2123796T3 (en) | DERIVATIVES OF PHOSPHONE-SUCCINIC ACIDS AND THEIR USE AS MEDICINES. | |
| PT92668A (en) | PROCESS FOR THE PREPARATION OF AZABICYCLO-HEPTANE DERIVATIVES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |